Showing results (331-340 of 343) with videos related to
Sort By:
Pageof 35
The Lancet. Respiratory Medicine|June 14, 2021
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trialAxel Bauer, Michael Schreinlechner, Nikolay Sappler, et al.Nature Immunology|July 20, 2017
A guiding map for inflammationMihai G Netea, Frances Balkwill, Michel Chonchol, et al.Gut|March 2, 2026
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statementChu-Tian Wu, Giovanni Targher, Christopher D Byrne, et al.United European Gastroenterology Journal|November 5, 2020
A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working groupJosbert J Keller, Rogier E Ooijevaar, Christian L Hvas, et al.Cell Reports|April 14, 2021
Dietary spermidine improves cognitive functionSabrina Schroeder, Sebastian J Hofer, Andreas Zimmermann, et al.Gut|September 27, 2015
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancerJun Yu, Qiang Feng, Sunny Hei Wong, et al.Inflammatory Bowel Diseases|February 11, 2025
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus ConferenceLoris R Lopetuso, Sara Deleu, Pierluigi Puca, et al.Nature|March 25, 2021
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASHMichael Dudek, Dominik Pfister, Sainitin Donakonda, et al.Hepatobiliary Surgery and Nutrition|June 23, 2023
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseDan-Qin Sun, Giovanni Targher, Christopher D Byrne, et al.Hepatology International|May 19, 2023
An international multidisciplinary consensus statement on MAFLD and the risk of CVDXiao-Dong Zhou, Giovanni Targher, Christopher D Byrne, et al.Pageof 35